Abstract: A teicoplanin derivative useful for treating an infectious disease, having the structure of formula (I): or the pharmaceutically acceptable salt, solvate, stereoisomer, derivative or prodrug thereof. In an exemplary compound of formula (I), R1 is R2 is H, R3 is —N(CH3)2, and R4 is H.

Abstract: Disclosed herein are novel compounds and uses thereof. The present compounds are useful in suppressing the growth of various bacteria, including gram-positive and gram-negative bacteria. Accordingly, these compounds may be used to manufacture a medicament or pharmaceutic composition for treating disease and/or disorders associated with bacterial infection, especially antibiotic-resistant bacterial infection. Al so disclosed herein are methods for treating infectious diseases by use of the present compounds, medicament or pharmaceutical composition.

Abstract: Described herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting bacterial growth.

Abstract: An electronic system including a first electronic device and a second electronic device and a method of switching operating systems thereof are provided. The first electronic device executes a first operating system. The second electronic device executes a second operating system. The operating system switch unit of the first electronic device includes an input and output switch unit and a logic determining circuit unit. The logic determining circuit unit determines whether the second electronic device is connected to the first electronic device to generate the connection information and determines whether to receive switch information which is generated by enabling a switch.

Abstract: Described herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting bacterial growth. Methods of using the compounds for treating and/or preventing bacterial infection as well as methods of preparing the compounds are also described.

Abstract: An encrypted wireless system with NFC function includes a detection module, an electronic control unit (ECU), and a mobile device. When the mobile device having the first NFC sensing module is near to the ECU having the second NFC sensing module, the ECU can be connected to the mobile device to trigger the car accordingly. In addition, the encryption chip of the mobile device encrypts the sensing data of the car, and the encrypted data are reporting to the car maintenance workshop via the mobile device. Hence, when the car cannot be operated normally, the car maintenance workshop can be rapidly introduced to help the car user figure and address the problems. Accordingly, better user experiences can be provided regarding the car operation, the feedback mechanism for the service center, and the data transmission between the mobile device and the ECU or between the mobile device and other NFC devices.

Abstract: Described herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting bacterial growth. Methods of using the compounds for treating and/or preventing bacterial infection as well as methods of preparing the compounds are also described.

Abstract: An electronic system including a first electronic device and a second electronic device and a method of switching operating systems thereof are provided. The first electronic device executes a first operating system. The second electronic device executes a second operating system. The operating system switch unit of the first electronic device includes an input and output switch unit and a logic determining circuit unit. The logic determining circuit unit determines whether the second electronic device is connected to the first electronic device to generate the connection information and determines whether to receive switch information which is generated by enabling a switch.

Abstract: A novel pharmaceutical composition comprising a compound of formula (I) is disclosed. The novel compound can include a pharmaceutically acceptable carrier. The invention further comprises methods for making compounds of formula (I) using Dbv29, and to the use of compound of formula (I) to treat bacterial infections.

Abstract: A novel pharmaceutical composition comprising a compound of formula (I) is disclosed. The novel compound can include a pharmaceutically acceptable carrier. The invention further comprises methods for making compounds of formula (I) using Dbv29, and to the use of compound of formula (I) to treat bacterial infections.

Abstract: A novel pharmaceutical composition comprising a compound of formula (I) is disclosed. The novel compound can include a pharmaceutically acceptable carrier. The invention further comprises methods for making compounds of formula (I) using Dbv29, and to the use of compound of formula (I) to treat bacterial infections.

Abstract: A novel pharmaceutical composition comprising a compound of formula (I) is disclosed. The novel compound can include a pharmaceutically acceptable carrier. The invention further comprises methods for making compounds of formula (I) using Dbv29, and to the use of compound of formula (I) to treat bacterial infections.